Table 5.

Median overall survival of patients treated with Docetaxel according to NLR score.

	Good	Intermediate	Poor	p-Value
MedianOS months (95% CI)	38.1 (30.0–NR)	26.1 (17.4–NR)	16.4 (8.8–NR)	Log rank 0.3
HR (95% CI)	Ref	1.11 (0.51–2.42)	1.49 (0.34–6.47)	Cox model 0.86

Hazard Ratio (HR), Not Reached (NR), Overall Survival (OS), Reference (Ref), Neutrophil to Lymphocyte Rate (NLR), Score: Good: NLR baseline ≤ 5 and NLR at 12 weeks ≤ 5, Intermediate: NLR at baseline < 5 and at 12 weeks > 5, Poor: NLR at baseline > 5 and NLR at 12 weeks > 5.